Vaccines

A study led by researchers at Stanford Medicine finds the benefit of frequent booster vaccination for COVID-19 is highest for those over 65 years and the immunocompromised.

In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.

Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

A gene signature seen in antibody-producing cells in the blood of vaccinated study participants could expedite vaccine development.

The mpox virus is normally endemic to Africa but has recently been found on other continents. It spreads through prolonged, direct contact with infected people or their bedding, clothing and towels.

Vaccinology has taken great leaps forward in the past decade, largely due to advanced analytical methods as well as a shift in researchers’ focus from rodents to humans.

During the 2021 fiscal year, the organization donated $464 million for the health of the local community.

Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.

Using household items, Stanford students have developed a way to make affordable nasal drops with the potential to slow the spread of viruses like COVID-19.

Two-dose COVID-19 vaccines significantly increase protection against hospitalization and death in people who had the illness before they were immunized.